Erick DeVinney
Corporate Officer/Principal at AXOGEN, INC.
Net worth: 1 M $ as of 2024-03-30
Erick DeVinney active positions
Companies | Position | Start | End |
---|---|---|---|
AXOGEN, INC. | Corporate Officer/Principal | 2024-01-03 | - |
Chief Tech/Sci/R&D Officer | 2007-03-31 | 2024-01-03 |
Career history of Erick DeVinney
Former positions of Erick DeVinney
Companies | Position | Start | End |
---|---|---|---|
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Chief Tech/Sci/R&D Officer | 2007-03-31 | 2013-12-31 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 2004-12-31 | 2006-12-31 |
National Clinical Research Centers, Inc.
National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., National Clinical Research Centers, Inc. is a private company that specializes in clinical trials management and pharmaceuticals. The company is based in Bethesda, MD. The company was founded by Stephen J. Trevisan. National Clinical Research Centers was acquired by Roberts Pharmaceutical Corp., part of Takeda Pharmaceutical Co., Ltd. from December 23, 1999 on April 07, 1992 for $6.25 million. | Corporate Officer/Principal | - | - |
Medical College of Virginia | Corporate Officer/Principal | - | - |
Training of Erick DeVinney
Virginia Commonwealth University | Undergraduate Degree |
Statistics
International
United States | 6 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AXOGEN, INC. | Health Technology |
Private companies | 3 |
---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
National Clinical Research Centers, Inc.
National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., National Clinical Research Centers, Inc. is a private company that specializes in clinical trials management and pharmaceuticals. The company is based in Bethesda, MD. The company was founded by Stephen J. Trevisan. National Clinical Research Centers was acquired by Roberts Pharmaceutical Corp., part of Takeda Pharmaceutical Co., Ltd. from December 23, 1999 on April 07, 1992 for $6.25 million. | Commercial Services |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Health Technology |
- Stock Market
- Insiders
- Erick DeVinney
- Experience